Hawaii natural compounds are promising to reduce ovarian cancer deaths.
作者:
Fei-Zhang(David J),Li(Chunshun),Cao(Shugeng)
状态:
发布时间2016-07-20
, 更新时间 2016-08-28
期刊:
Cancer Biol Ther
摘要:
The low survival rate of patients with ovarian cancer largely results from the advanced ovarian tumors as well as tumor resistance to chemotherapy, leading to metastasis and recurrence. However, it is missing as to an effective therapeutic approach that focuses on these aspects to prolong progression-free survival and to decrease mortality in ovarian cancer patients. Here, based on our cancer drug discovery studies, we provide prospective insights into the development of a future line of drugs to effectively reduce ovarian cancer deaths. Pathways that increase the probability of cancer, such as the defective Fanconi anemia (FA) pathway, may render cancer cells more sensitive to new drug targeting.